USD 5.19 billion
Acute Pancreatitis Market Size, Share, Growth Analysis, By Diagnosis(Imaging tests and Laboratory tests), By End-User(Hospitals and Clinics), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2197 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
59
|Figures:
75
Acute Pancreatitis Market Insights
The Acute Pancreatitis Market size was valued at USD 5.50 billion in 2022 and is poised to grow from USD 5.82 billion in 2023 to USD 9.21 billion by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031)
The global acute pancreatitis market refers to the collective market landscape associated with the diagnosis, treatment, and management of acute pancreatitis worldwide. Acute pancreatitis is a severe medical condition characterized by the sudden inflammation of the pancreas, which can cause significant complications and even be life-threatening in some cases. The market for acute pancreatitis is driven by several factors, including the rising prevalence of the condition, advancements in diagnostic techniques, and the development of novel treatment options. Additionally, an increase in risk factors such as obesity, alcohol consumption, gallstones, and certain medications has contributed to the growing incidence of acute pancreatitis globally. The global acute pancreatitis market is highly competitive, with several pharmaceutical companies, medical device manufacturers, and healthcare providers actively participating in research, development, and commercialization of innovative solutions. Key market players are investing in clinical trials, collaborations, and strategic partnerships to enhance their product portfolios and gain a competitive edge. In conclusion, the global acute pancreatitis market encompasses a wide range of diagnostic, therapeutic, and supportive care solutions aimed at addressing the challenges associated with this serious medical condition. The market is driven by advancements in technology, increasing prevalence, and the need for effective treatment options. Ongoing research and development efforts, along with collaborative approaches, are expected to drive innovation and improve outcomes for patients with acute pancreatitis.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Hospitals
Fastest Growth
Hospitals
Growth Rate
5.9% CAGR
Global Acute Pancreatitis Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Acute Pancreatitis Market Segmental Analysis
The Global Acute Pancreatitis Market is segmented by diagnosis, end-user, and region. Based on diagnosis, the market can be segmented into imaging tests and laboratory tests. Based on end-user, the market is segmented into hospitals and clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Acute Pancreatitis Market Analysis by Diagnosis
By diagnosis, the market can be segmented into imaging tests and laboratory tests. Imaging tests hold a dominant position in the global acute pancreatitis market. These tests play a crucial role in the accurate and timely diagnosis of acute pancreatitis by providing visualizations of the pancreas and surrounding structures. Common imaging techniques used in the diagnosis of acute pancreatitis include ultrasound, computed tomography (CT) scans, magnetic resonance imaging (MRI), and endoscopic retrograde cholangiopancreatography (ERCP). These imaging tests enable healthcare professionals to assess the extent of inflammation, identify complications, and guide treatment decisions. The dominance of imaging tests can be attributed to their widespread availability, established diagnostic accuracy, and the ability to visualize the pancreas and related structures in detail.
Laboratory tests are the fastest-growing segment in the global acute pancreatitis market. Laboratory tests are used to assess pancreatic enzyme levels, such as serum amylase and lipase, which are elevated in cases of acute pancreatitis. These tests aid in confirming the diagnosis, monitoring disease progression, and evaluating treatment response. The growing awareness about the importance of early and accurate diagnosis, along with advancements in laboratory testing techniques, contributes to the increasing adoption of laboratory tests. Additionally, the development of novel biomarkers and point-of-care testing options further drives the growth of laboratory tests in the acute pancreatitis market.
Acute Pancreatitis Market Analysis by End-User
By end-user, the market can be segmented into hospitals and clinics. The hospital segment represents the dominating segment in the Acute Pancreatitis market. Hospitals play a crucial role in the diagnosis, treatment, and management of acute pancreatitis. They serve as primary healthcare settings where patients seek medical attention for acute pancreatitis-related symptoms. Hospitals typically have specialized departments, such as gastroenterology and hepatology, equipped with advanced diagnostic tools and a multidisciplinary team of healthcare professionals. These resources enable comprehensive evaluations, including laboratory tests, imaging studies, and interventional procedures, ensuring accurate diagnosis and appropriate treatment.
Clinics segment has emerged as the fastest-growing segment in the Acute Pancreatitis market. Clinics, particularly specialized gastroenterology clinics, are emerging as essential healthcare settings for the diagnosis and management of acute pancreatitis. These clinics provide focused care, expertise, and outpatient services for patients with acute pancreatitis. Clinics offer advantages such as shorter waiting times, easier accessibility, and a more personalized approach to patient care. They are well-equipped with diagnostic tools, including laboratory facilities for blood tests, imaging equipment for ultrasounds and CT scans, and endoscopic capabilities for procedures such as ERCP. Clinics also provide follow-up care, regular monitoring, and lifestyle management guidance for patients with chronic pancreatitis, ensuring long-term disease management.
Global Acute Pancreatitis Market By End User
To get detailed analysis on other segments, Request For Free Sample Report
Acute Pancreatitis Market Regional Insights
North America dominates the global Acute Pancreatitis market. This can be attributed to several factors, including a high prevalence of risk factors such as obesity and alcohol consumption, advanced healthcare infrastructure, and strong government initiatives promoting early diagnosis and treatment. The region is also home to several key market players, including pharmaceutical companies and medical device manufacturers, who are actively engaged in research and development activities. Furthermore, well-established reimbursement policies and a high level of awareness among healthcare professionals contribute to the dominance of North America in the acute pancreatitis market.
Asia Pacific is expected to be the fastest growing region in the global Acute Pancreatitis market. Factors such as a large population base, increasing healthcare expenditure, and improving healthcare infrastructure are driving the market growth in this region. Additionally, the rising prevalence of risk factors such as alcohol consumption, changing dietary patterns, and increasing obesity rates contribute to the growing incidence of acute pancreatitis. Governments in countries like China and India are investing in healthcare reforms and initiatives to improve diagnosis and treatment options. Furthermore, the presence of a large pool of patients, coupled with the growing adoption of advanced technologies, offers significant opportunities for market growth in the Asia Pacific region.
Global Acute Pancreatitis Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Acute Pancreatitis Market Dynamics
Acute Pancreatitis Market Drivers
Rising incidences of diabetes and government initiatives
- The market's growth rate is anticipated to be accelerated by the rising prevalence of diabetes. Cells that make insulin can be harmed by pancreatitis. The pancreas secretes the hormone insulin, which aids in controlling blood sugar levels. Nearly 45 percent of people with chronic pancreatitis develop diabetes when the disease destroys these cells. Additionally, the market for pancreatitis will grow because of an increase in elderly population and government measures to raise awareness. Along with this, shifting consumer lifestyles and expanding government-welcoming measures will accelerate market expansion. Additionally, increasing rates of obesity and pancreatic cancer will spur market expansion.
Acute Pancreatitis Market Restraints
High cost associated with the treatment
- The market for pancreatitis will expand slowly because of the high cost of the related treatment. The pancreatitis market will be challenged by the absence of healthcare facilities in developing economies and the rigorous regulatory environment. Additionally, poor reimbursement practises and a lack of public awareness will serve as restraints and slow the market's development pace even more.
Request Free Customization of this report to help us to meet your business objectives.
Acute Pancreatitis Market Competitive Landscape
Details about each competitor are included in the competitive landscape for pancreatitis. The company's financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are among the details that are included. The statistical points mentioned here simply speak to the companies' market-related pancreatic emphasis.
Acute Pancreatitis Market Top Player’s Company Profiles
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Baxter (U.S.)
- Bayer AG (Germany)
- Eli Lilly and Company (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Allergan (Ireland)
- AbbVie Inc. (U.S.)
- Abbott (U.S.)
- Bausch Health Companies Inc. (Canada)
Acute Pancreatitis Market Recent Developments
- In December 2022, Auxora is a part of Phase II clinical dose-ranging study being carried out by CalciMedica, Inc. in patients with acute pancreatitis and systemic inflammatory response syndrome.
- In March 2022, Comparative statistics between Nafamostat and citrate anticoagulation (RCA), two separate dialysis circuit anticoagulants, were presented by AcelRx Pharmaceuticals, Inc. in paediatric patients on continuous renal replacement therapy (CRRT). A serine protease inhibitor called nafamostat is used to treat acute pancreatitis.
Acute Pancreatitis Key Market Trends
- Several key market trends are shaping the landscape of the global acute pancreatitis market. Firstly, there is a growing focus on early diagnosis and intervention. Healthcare providers and researchers are placing emphasis on improving diagnostic techniques and developing tools for early detection of acute pancreatitis. This trend aims to enable prompt treatment initiation and minimize complications. Another significant trend is the increasing adoption of personalized medicine approaches. With advancements in genetic testing and molecular diagnostics, there is a growing understanding of the individual variations in the development and progression of acute pancreatitis. This knowledge is leading to the development of targeted therapies and precision medicine approaches tailored to specific patient profiles. Overall, the key market trends in the global acute pancreatitis market revolve around early diagnosis, minimally invasive interventions, personalized medicine, digital health integration, and the pursuit of novel therapeutic approaches. These trends are expected to shape the future of acute pancreatitis management, offering improved outcomes and enhanced patient care.
Acute Pancreatitis Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global acute pancreatitis market refers to the market landscape for the diagnosis, treatment, and management of acute pancreatitis worldwide. This condition involves the sudden inflammation of the pancreas and can be life-threatening. Factors such as increasing prevalence, advancements in diagnostics, and the development of new treatments are driving the market. Diagnostic tools, pharmaceuticals, surgical interventions, and supportive care products are key segments within the market. These include laboratory tests, imaging techniques, pain management medications, surgical procedures, and nutritional supplements. The market is competitive, with companies investing in research, clinical trials, and collaborations to enhance their product portfolios. Government initiatives, healthcare infrastructure development, and increased awareness also contribute to market growth. Challenges include high treatment costs, limited awareness in some regions, and the complexity of the disease. Overall, ongoing research and development efforts aim to improve outcomes and provide innovative solutions for patients with acute pancreatitis.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.50 billion |
| Market size value in 2031 | USD 9.21 billion |
| Growth Rate | 5.9% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Acute Pancreatitis Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Acute Pancreatitis Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Acute Pancreatitis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Acute Pancreatitis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Acute Pancreatitis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Acute Pancreatitis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
